Lenshil, Lenvatinib

Lenshil Lenvatinib is used for the treatment of thyroid cancer as a chemotherapy drug.





Shilpa Medicare Limited


4 mg, 10 mg



Lenshil is used as a targeted therapy drug which is used for the treatment of metastatic and progressive thyroid cancer.
How it Works
Lenshil works to bind to tyrosine kinase receptors and it inhibits vascular epidermal growth factor receptors (VEGFR), VEGFR then inhibits other kinase receptors which have an effect on angiognesis, tumor growth and cancer progression. By binding to VEGFR receptors  Lenshil works to block the  pathways that promote cell division
Common Side effects
Some of the side effects related with taking Lenshil are as belowHigh blood pressureHeadacheOral painCoughSwellingRashTaste changesDry mouthDiarrheaFatigueVomitingAbdominal painJoint/muscle achesDecreased appetiteWeight lossNauseaMouth soresDizzinessHeartburnHair loss
Expert advice
If you are experiencing a fever of 38 degrees Celsius or higher, experiencing shortness of breath, chest pains or pains in your arms,weakness in one side of the body or sudden vision changes please go to the emergency room immediately. 
Store  Lenshil in a cold dry place away from direct sunlight

Customers also bought

Popular Products

Similar Product